Consistent with these findings, Eren et al. [101] also suggested that TXNIP could mediate as part of a fetal compensatory mechanism to mitigate oxidative stress in GDM, revealing a higher TRX/TXNIP ratio in the serum of GDM patients during the early second trimester compared to controls. The gene discussed is TXN; the disease is gestational diabetes.